FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: D-2-hydroxyglutaric aciduria 2
Open Close
General Information
Name
D-2-hydroxyglutaric aciduria 2
FlyBase ID
FBhh0000103
Disease Ontology Term
Parent Disease
Overview

This report describes D-2-hydroxyglutaric aciduria 2 (D2HGA2), which is a sub-type of D-2-hydroxyglutaric aciduria (D2HGA); D2HGA2 exhibits autosomal dominant inheritance. The human gene implicated in this disease is IDH2, which is a mitochondrial NADP-dependent isocitrate dehydrogenase. There is a single fly ortholog, Dmel\Idh, for which classical amorphic and loss-of-function alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated. Dmel\Idh is a high scoring ortholog of a second isocitrate dehydrogenase gene in humans, IDH1, which is associated with susceptibility to malignant glioma (MIM:137800). Somatic mutations of both IDH1 and IDH2 have been implicated in the development of multiple cancers; see the report for 'cancer, multiple, IDH1,2-related,' FBhh0000525.

Neither human gene, IDH2 nor IDH1, has been introduced into flies.

Variant(s) implicated in human disease tested (as analogous mutation in fly gene): R163Q in the fly Idh gene (corresponds to R140Q in the human IDH2 gene). Ubiquitous expression of a transgenic gene carrying the R163Q variant results in elevation of D-2-hydroxyglutarate levels. Amorphic mutations of Dmel\Idh are homozygous lethals. Genetic and physical interactions have been described for Dmel\Idh; see below and in the FlyBase gene report for Idh.

[updated Sep. 2017 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: D-2-hydroxyglutaric aciduria
Symptoms and phenotype

D-2-hydroxyglutaric aciduria is a neurometabolic disorder. Symptoms are varible, ranging from asymptomatic to developmental delay, epilepsy, hypotonia (weak muscle tone), and dysmorphic features. Severe cases are characterized by early infantile-onset epileptic encephalopathy and, often, cardiomyopathy. [from MIM:600721, MIM:613657; 2015.12.21]

Specific Disease Summary: D-2-hydroxyglutaric aciduria 2
OMIM report

[D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2](https://omim.org/entry/613657)

Human gene(s) implicated

[ISOCITRATE DEHYDROGENASE, NADP(+), 2; IDH2](https://omim.org/entry/147650)

Symptoms and phenotype

See general description of D-2-hydroxyglutaric aciduria, above.

Genetics

The transmission pattern of D-2-hydroxyglutaric aciduria-2 in the families reported by Kranendijk et al. (2010; pubmed:20847235) is consistent with autosomal dominant inheritance. D2HGA2 appears to be caused by heterozygous mutations in the mitochondrial isocitrate dehydrogenase-2 (IDH2) gene. [from MIM:613657; 2015.12.21]

Cellular phenotype and pathology
Molecular information

Isocitrate dehydrogenase-2 (IDH2) is a mitochondrial NADP-dependent isocitrate dehydrogenase. By providing NADPH for NADPH-dependent antioxidant enzymes, IDH2 plays a role in controlling the mitochondrial redox balance and mitigating cellular oxidative damage (Park et al., 2008; pubmed:18484410). [from MIM:147650; 2015.12.21]

External links
Disease synonyms
2-hydroxyglutaric aciduria
D2HGA2
D-2-hydroxyglutaric aciduria
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 2 human to 1 Drosophila. Two human genes, IDH1 and IDH2, are orthologous to the fly gene Dmel\Idh.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      Isocitrate dehydrogenase (Idh) encodes a cytosolic enzyme that catalyzes the oxidative decarboxylation of isocitrate to 2-oxoglutarate, with the concomitant reduction of NADP[+] to NADPH. It functions, along with Men, G6pd, and Pgd, in a small network of NADP reducing enzymes. [Date last reviewed: 2019-03-07]
      Gene Groups / Pathways
      Comments on ortholog(s)

      Lower-scoring ortholog of IDH2; higher-scoring ortholog of second human gene, IDH1 (1 Drosphila to 2 human). Dmel\Idh shares 65% identity and 80% similarity with the human IDH2 gene; it shares 72% identity and 87% similarity with the human IDH1 gene.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (3 groups)
        protein-protein
        Interacting group
        Assay
        References
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (3 alleles)
        Models Based on Experimental Evidence ( 2 )
        Modifiers Based on Experimental Evidence ( 1 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        loss of function allele
        P-element activity
        loss of function allele
        natural population
        loss of function allele
        natural population
        loss of function allele
        natural population
        amorphic allele - molecular evidence
        Delta2-3 transposase
        References (5)